|
BioSense is a program of the Centers for Disease Control and Prevention (CDC) that tracks health problems as they evolve and provides public health officials with the data, information and tools they need to better prepare for and coordinate responses to safeguard and improve the health of the American people. By integrating local and state-level information, CDC will provide a timely and cohesive picture at the regional (i.e., multistate) and national levels and improve BioSense's utility. The key components of the BioSense program redesign are to: *Help build health monitoring infrastructure and workforce capacity where needed at the state, local, tribal, and territorial levels *Facilitate the interchange of information that can be used to coordinate responses and monitor health-related outcomes routinely and during an event *Retain the original purpose of BioSense to detect and characterize events (or health-related threats) early by building on state and local health departments systems and programs *Expand the utility of BioSense data to multi-use (all-hazard ) beyond early event detection and to contribute information for public health situational awareness, routine public health practice, and improved health outcomes and public health *Improve the ability to detect emergency health-related threats by supporting the enhancement of systems to signal alerts for potential problems *Increasing local and state jurisdictions participation in BioSense *Advances in science and technology 〔(【引用サイトリンク】title=BioSense )〕 ==BioSense Mandate and Establishment== Mandated in the Public Health Security and Bioterrorism Preparedness Response Act of 2002, the CDC BioSense Program was launched in 2003 to establish an integrated national public health surveillance system for early detection and rapid assessment of potential bioterrorism-related illness. 〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「BioSense」の詳細全文を読む スポンサード リンク
|